Business Segments Abpro Bio Co., Ltd.
Equities
A195990
KR7195990007
Industrial Machinery & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,400.00 KRW | -7.28% |
|
-.--% | -46.15% |
| 25-10-01 | Investors left reading tea leaves | |
| 25-08-25 | Abpro Bio Co., Ltd.(KOSDAQ:A195990) dropped from S&P Global BMI Index | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Machinery Components | ||||||||||
Machine Tool Sector | 38.22B | 34.9B | 22.8B | 13.43B | 24.2B | |||||
Total Assets | 191B | 204B | 189B | 174B | 139B | |||||
Interest Expense | -4.93B | -6.85B | -4.58B | -2.14B | -1.76B | |||||
Income Tax Expense | 3.51B | 64.59M | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 5.5B | 2.49B | 1.21B | 1.5B | 1.02B | |||||
Operating Income | -937M | -2.46B | -7.57B | -9.34B | -7.11B | |||||
Net Income | -55.22B | -2.37B | -9.87B | -18.44B | -41.09B | |||||
Pharmaceutical Sector | - | - | - | - | 6.5B | |||||
Total Assets | - | - | - | - | 10.52B | |||||
Interest Expense | - | - | - | - | -27.25M | |||||
Income Tax Expense | - | - | - | - | 38.88M | |||||
D&A | - | - | - | - | 34.36M | |||||
Operating Income | - | - | - | - | 264M | |||||
Net Income | - | - | - | - | 143M | |||||
Semiconductor Sector | - | - | - | 12.44B | 5.94B | |||||
Total Assets | - | - | - | 10.74B | 10.53B | |||||
Interest Expense | - | - | - | -201M | -339M | |||||
Income Tax Expense | - | - | - | 84.12M | -411M | |||||
D&A | - | - | - | 220M | 305M | |||||
Operating Income | - | - | - | 1.27B | -2.11B | |||||
Net Income | - | - | - | 973M | -1.56B | |||||
Other Sectors | 13.48B | - | - | - | - | |||||
Total Assets | 67.13B | 48.25B | 65.38B | 59.71B | 45.13B | |||||
Interest Expense | -1.15B | -1.11B | -1.55B | -1.84B | -2.16B | |||||
Income Tax Expense | 4.44M | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 822M | 115M | 192M | 145M | 52.19M | |||||
Operating Income | -4.21B | -1.38B | -1.11B | -861M | -237M | |||||
Net Income | -20.79B | -8.82B | 1.34B | -12.19B | -30.04B | |||||
Machinery & Industrial Equipment | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Elimination of Internal Transactions | -2.42B | -1.99B | -692M | -496M | -4.97B | |||||
Total Assets | -91.98B | -83.98B | -97.88B | -102B | -64.04B | |||||
Interest Expense | 1.04B | 1.11B | 1.53B | 1.84B | 2.19B | |||||
Income Tax Expense | -1.07B | - | - | - | -53.69M | |||||
CAPEX | - | - | - | - | - | |||||
D&A | 928M | -16.8M | - | - | 73.21M | |||||
Operating Income | -995M | -351M | 75.04M | 127M | -1.01B | |||||
Net Income | 14.39B | 1.45B | 384M | 3.91B | 56.92B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
South Korea | 19.66B | 7.09B | 14.89B | 19.13B | 27.14B | |||||
Total Assets | 24.41B | 19.52B | 18.87B | 18.83B | 17.85B | |||||
China | 15.48B | 24.43B | 6.38B | 5.49B | 4.48B | |||||
Total Assets | 15.14B | 3.09B | 2.77B | 2.13B | 2.15B | |||||
Other | 3.75B | 1.39B | 845M | 755M | 43.31M | |||||
Philippines | 10.39B | - | - | - | - | |||||
Vietnam | - | - | - | - | - |
- Stock Market
- Equities
- A195990 Stock
- Financials Abpro Bio Co., Ltd.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















